The Latest: FDA advisers endorse gene therapy for blindness

The Latest: FDA advisers endorse gene therapy for blindness

Dr. Barry Byrne listens to testimony concerning the approval of a potentially breakthrough drug for a form of blindness during a meeting of the The Cellular, Tissue and Gene Therapies advisory committee, Thursday, Oct. 12. 2017, at the FDA in Silver Spring, Md. (AP Photo/Nick Wass)
Christian Guardino of the Long Island borough of New York testifies during a meeting with the Cellular, Tissue and Gene Therapies advisory committee concerning the approval of a potentially breakthrough drug for a form of blindness, Thursday, Oct. 12. 2017, at the FDA in Silver Spring, Md. (AP Photo/Nick Wass)

The Latest: FDA advisers endorse gene therapy for blindness

Dr. Barry Byrne listens to testimony concerning the approval of a potentially breakthrough drug for a form of blindness during a meeting of the The Cellular, Tissue and Gene Therapies advisory committee, Thursday, Oct. 12. 2017, at the FDA in Silver Spring, Md. (AP Photo/Nick Wass)
Christian Guardino of the Long Island borough of New York testifies during a meeting with the Cellular, Tissue and Gene Therapies advisory committee concerning the approval of a potentially breakthrough drug for a form of blindness, Thursday, Oct. 12. 2017, at the FDA in Silver Spring, Md. (AP Photo/Nick Wass)
click here to add your event
Bayfield ~ Events
click here to add your event
Bayfield ~ Events